Our group has conducted several preclinical animal model studies to suggest that supplementation of diet with fatty acids, such as conjugated linoleic acid (CLA) [8], [19] or agonistic botanicals, is effective at ameliorating colonic inflammation in mouse and pig models of IBD through a PPARγ-dependent mechanism [8], [19]–[21]. This evidence concerns the gene PPARG and inflammatory bowel disease.